Article

Survivin Promotes the Formation of a Microtubule-Based Glycolytic Hub

2026-08-31

Abstract excerpt

KRAS is one of the most frequently mutated oncoproteins in cancer. Its ability to induce malignant transformation relies on metabolic reprogramming that causes cells to become dependent on aerobic glycolysis as a primary source of energy and for generating biological building blocks. Thus far, the signaling mechanism used by oncogenic KRAS to promote these changes in cancer cell metabolism has not been fully eluci...

Identifiers and source

Literature Corpus work: 68b5215a-6148-5ddb-8305-92efc08398ff
DOI: 10.64898/2026.08.28.747899

Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest

Survivin Promotes the Formation of a Microtubule-Based Glycolytic HubDOI 10.64898/2026.08.28.747899Read

The complex landscape of pancreatic cancer metabolismSemantic proximity Read

Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma.Semantic proximity Read

Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets.Semantic proximity Read

Metabolic reprogramming in KRAS-mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies.Semantic proximity Read

Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinomaSemantic proximity Read

Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)Semantic proximity Read

The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunitiesSemantic proximity Read

Unraveling the intricacies of cancer‐associated fibroblasts: a comprehensive review on metabolic reprogramming and tumor microenvironment crosstalkSemantic proximity Read

Glycometabolic rearrangements–aerobic glycolysis in pancreatic ductal adenocarcinoma (PDAC): roles, regulatory networks, and therapeutic potentialSemantic proximity Read

The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic CancerSemantic proximity Read

Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer ProgressionSemantic proximity Read

Targeting metabolic reprogramming in KRAS-driven cancers.Semantic proximity Read